Company Overview of TxCell S.A.
TxCell S.A., a biotechnology company, develops therapies to cure inflammatory and autoimmune diseases. Its products include OvaSave, which is being evaluated to treat Crohn's disease patients that resist to conventional treatments. The company’s products also include RA1-TX, which is used for the treatment of Rheumatoid Arthritis. TxCell S.A. was founded in 2001 and is based in Valbonne, France.
Allée de la Nertière – Les
Founded in 2001
33 4 97 21 83 00
33 4 93 64 15 80
Key Executives for TxCell S.A.
Similar Private Companies By Industry
|Laboratoire Tetra Medical||Europe|
|Abbott Products S.A.S.||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- New York, NY | AstraZenecaPosted: Dec 12
- Parsippany, NJ | RGPPosted: Nov 27
- Louisville, KY | AstraZenecaPosted: Dec 12
- Princeton, NJ | RGPPosted: Oct 21
Sponsored Financial Commentaries
To contact TxCell S.A., please visit www.txcell.com. Company data is provided by Capital IQ. Please use this form to report any data issues.